{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:35:38Z","timestamp":1773797738814,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014965","name":"Endometriosis Foundation of America","doi-asserted-by":"publisher","award":["AWD0003567"],"award-info":[{"award-number":["AWD0003567"]}],"id":[{"id":"10.13039\/100014965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014965","name":"Endometriosis Foundation of America","doi-asserted-by":"publisher","award":["AWD0003567"],"award-info":[{"award-number":["AWD0003567"]}],"id":[{"id":"10.13039\/100014965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014965","name":"Endometriosis Foundation of America","doi-asserted-by":"publisher","award":["AWD0003567"],"award-info":[{"award-number":["AWD0003567"]}],"id":[{"id":"10.13039\/100014965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014965","name":"Endometriosis Foundation of America","doi-asserted-by":"publisher","award":["AWD0003567"],"award-info":[{"award-number":["AWD0003567"]}],"id":[{"id":"10.13039\/100014965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014965","name":"Endometriosis Foundation of America","doi-asserted-by":"publisher","award":["AWD0003567"],"award-info":[{"award-number":["AWD0003567"]}],"id":[{"id":"10.13039\/100014965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014965","name":"Endometriosis Foundation of America","doi-asserted-by":"publisher","award":["AWD0003567"],"award-info":[{"award-number":["AWD0003567"]}],"id":[{"id":"10.13039\/100014965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH U54 HD052668"],"award-info":[{"award-number":["NIH U54 HD052668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH U54 HD052668"],"award-info":[{"award-number":["NIH U54 HD052668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH U54 HD052668"],"award-info":[{"award-number":["NIH U54 HD052668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH U54 HD052668"],"award-info":[{"award-number":["NIH U54 HD052668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH U54 HD052668"],"award-info":[{"award-number":["NIH U54 HD052668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH U54 HD052668"],"award-info":[{"award-number":["NIH U54 HD052668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To investigate the function of HOXA11-antisense long non-coding RNA (HOXA11-AS) in endometriosis treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Tissue samples (ectopic and eutopic endometrium) were obtained from surgically diagnosed subjects with endometriosis (<jats:italic>n<\/jats:italic>\u2009=\u200915) and controls (<jats:italic>n<\/jats:italic>\u2009=\u200911) without endometriosis after treatment with a progestin. RNA was extracted from these tissues; cDNA was prepared and lncRNA HOXA11-AS levels were measured by quantitative real-time polymerase chain reaction (RT-qPCR). Immortalized endometrial stromal cells from an endometriosis patient (ENDO cell line) were cultured and transfected by HOXA11-AS plasmid and potential target genes were analyzed by RT-qPCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Progestin therapy led to lower lncRNA <jats:italic>HOXA11-AS<\/jats:italic> expression. HOXA11-AS was most decreased in ectopic endometriotic lesions, lower by 81% compared to eutopic endometrium from women with endometriosis. There was no difference in progestin response between eutopic endometrium in endometriosis and normal endometrium from controls. A HOXA11-AS plasmid was used to increase HOXA11-AS expression in an endometriotic cell line. Increased HOXA11-AS led to a significant increase in the expression of genes ITGB3, AKT1, MMP2, and MMP9, which have a role in cell proliferation and tumorigenesis. HOXA11-AS also upregulated the mRNA levels of tumor suppressor and apoptotic regulatory genes PTEN, BCL2 and Caspase3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>HOXA11-AS is a critical regulator of normal endometrial development. HOXA11-AS is elevated in endometriosis contributes to its pathophysiology. This long non-coding RNA was decreased in women undergoing endometriosis treatment with progestins. HOXA11-AS regulated several key drivers of disease and repression during treatment likely has a central role in preventing growth and invasion of endometriosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12958-025-01420-0","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:01:53Z","timestamp":1748836913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of long non-coding ribonucleic acid HOXA11-AS in endometriosis therapy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4022-8910","authenticated-orcid":false,"given":"Ramanaiah","family":"Mamillapalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimisha","family":"Gawde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Fay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rula","family":"Atwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Moridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"1420_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1248\/yakushi.20-00002","volume":"140","author":"T Kimura","year":"2020","unstructured":"Kimura T. [Non-coding natural antisense RNA: mechanisms of action in the regulation of target gene expression and its clinical implications]. Yakugaku Zasshi. 2020;140:687\u2013700.","journal-title":"Yakugaku Zasshi"},{"key":"1420_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2019.01.019","volume":"35","author":"R Esposito","year":"2019","unstructured":"Esposito R, Bosch N, Lanz\u00f3s A, Polidori T, Pulido-Quetglas C, Johnson R. Hacking the Cancer genome: profiling therapeutically actionable long Non-coding RNAs using CRISPR-Cas9 screening. Cancer Cell. 2019;35:545\u201357.","journal-title":"Cancer Cell"},{"key":"1420_CR3","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775\u201389.","journal-title":"Genome Res"},{"key":"1420_CR4","doi-asserted-by":"publisher","first-page":"598817","DOI":"10.3389\/fonc.2020.598817","volume":"10","author":"N Gao","year":"2020","unstructured":"Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, Liu H, Fan T. Long Non-Coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020;10:598817.","journal-title":"Front Oncol"},{"key":"1420_CR5","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73:2491\u2013509.","journal-title":"Cell Mol Life Sci"},{"key":"1420_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1534\/genetics.112.146704","volume":"193","author":"JT Kung","year":"2013","unstructured":"Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193:651\u201369.","journal-title":"Genetics"},{"key":"1420_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/7734","volume":"21","author":"JT Lee","year":"1999","unstructured":"Lee JT, Davidow LS, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet. 1999;21:400\u20134.","journal-title":"Nat Genet"},{"key":"1420_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/gcc.22709","volume":"58","author":"L Lorenzi","year":"2019","unstructured":"Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ, Speleman F, Vandesompele J, Mestdagh P. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58:191\u20139.","journal-title":"Genes Chromosomes Cancer"},{"key":"1420_CR9","doi-asserted-by":"crossref","unstructured":"Alessio E, Bonadio RS, Buson L, Chemello F, Cagnin S. A single cell but many different transcripts: A journey into the world of long Non-Coding RNAs. Int J Mol Sci 2020, 21.","DOI":"10.3390\/ijms21010302"},{"key":"1420_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.acc.2019.08.003","volume":"95","author":"R Choudhari","year":"2020","unstructured":"Choudhari R, Sedano MJ, Harrison AL, Subramani R, Lin KY, Ramos EI, Lakshmanaswamy R, Gadad SS. Long noncoding RNAs in cancer: from discovery to therapeutic targets. Adv Clin Chem. 2020;95:105\u201347.","journal-title":"Adv Clin Chem"},{"key":"1420_CR11","first-page":"25","volume":"989","author":"MP Scott","year":"1989","unstructured":"Scott MP, Tamkun JW, Hartzell GW. 3rd: the structure and function of the homeodomain. Biochim Biophys Acta. 1989;989:25\u201348.","journal-title":"Biochim Biophys Acta"},{"key":"1420_CR12","doi-asserted-by":"publisher","first-page":"34745","DOI":"10.18632\/oncotarget.5784","volume":"6","author":"EJ Richards","year":"2015","unstructured":"Richards EJ, Permuth-Wey J, Li Y, Chen YA, Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, et al. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. Oncotarget. 2015;6:34745\u201357.","journal-title":"Oncotarget"},{"key":"1420_CR13","first-page":"1737","volume":"43","author":"C Wei","year":"2020","unstructured":"Wei C, Zhao L, Liang H, Zhen Y, Han L. Recent advances in unraveling the molecular mechanisms and functions of HOXA11\u2013AS in human cancers and other diseases (Review). Oncol Rep. 2020;43:1737\u201354.","journal-title":"Oncol Rep"},{"key":"1420_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2017.09.015","volume":"474","author":"N Li","year":"2017","unstructured":"Li N, Yang M, Shi K, Li W. Long non-coding RNA HOXA11-AS in human cancer: A meta-analysis. Clin Chim Acta. 2017;474:165\u201370.","journal-title":"Clin Chim Acta"},{"key":"1420_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-017-0498-3","volume":"18","author":"S Mu","year":"2018","unstructured":"Mu S, Ai L, Fan F, Sun C, Hu Y. Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis. Cancer Cell Int. 2018;18:1.","journal-title":"Cancer Cell Int"},{"key":"1420_CR16","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/cam4.1571","volume":"7","author":"CW Lu","year":"2018","unstructured":"Lu CW, Zhou DD, Xie T, Hao JL, Pant OP, Lu CB, Liu XF. HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising LncRNA in human cancers. Cancer Med. 2018;7:3792\u20139.","journal-title":"Cancer Med"},{"key":"1420_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biopha.2015.04.010","volume":"72","author":"J Chen","year":"2015","unstructured":"Chen J, Fu Z, Ji C, Gu P, Xu P, Yu N, Kan Y, Wu X, Shen R, Shen Y. Systematic gene microarray analysis of the LncRNA expression profiles in human uterine cervix carcinoma. Biomed Pharmacother. 2015;72:83\u201390.","journal-title":"Biomed Pharmacother"},{"key":"1420_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4143\/crt.2016.263","volume":"49","author":"GW Yim","year":"2017","unstructured":"Yim GW, Kim HJ, Kim LK, Kim SW, Kim S, Nam EJ, Kim YT. Long Non-coding RNA HOXA11 antisense promotes cell proliferation and invasion and predicts patient prognosis in serous ovarian Cancer. Cancer Res Treat. 2017;49:656\u201368.","journal-title":"Cancer Res Treat"},{"key":"1420_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/1933719109334260","volume":"16","author":"KA Connell","year":"2009","unstructured":"Connell KA, Guess MK, Chen HW, Lynch T, Bercik R, Taylor HS. HOXA11 promotes fibroblast proliferation and regulates p53 in uterosacral ligaments. Reprod Sci. 2009;16:694\u2013700.","journal-title":"Reprod Sci"},{"key":"1420_CR20","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1210\/jcem.87.6.8527","volume":"87","author":"YM Chau","year":"2002","unstructured":"Chau YM, Pando S, Taylor HS. HOXA11 Silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium. J Clin Endocrinol Metab. 2002;87:2674\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ymthe.2022.01.036","volume":"30","author":"H Zhao","year":"2022","unstructured":"Zhao H, Hu S, Qi J, Wang Y, Ding Y, Zhu Q, He Y, Lu Y, Yao Y, Wang S, et al. Increased expression of HOXA11-AS attenuates endometrial decidualization in recurrent implantation failure patients. Mol Ther. 2022;30:1706\u201320.","journal-title":"Mol Ther"},{"key":"1420_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.ymthe.2022.03.007","volume":"30","author":"HS Taylor","year":"2022","unstructured":"Taylor HS. Uterine HOXA11 antisense long non-coding RNA prevents decidualization: A new pathway-regulating pregnancy. Mol Ther. 2022;30:1357\u20138.","journal-title":"Mol Ther"},{"key":"1420_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397:839\u201352.","journal-title":"Lancet"},{"key":"1420_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/09513590.2019.1588244","volume":"35","author":"D Deiana","year":"2019","unstructured":"Deiana D, Gessa S, Anardu M, Daniilidis A, Nappi L, D\u2019Alterio MN, Pontis A, Angioni S. Genetics of endometriosis: a comprehensive review. Gynecol Endocrinol. 2019;35:553\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"1420_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1530\/REP-19-0005","volume":"157","author":"J Liu","year":"2019","unstructured":"Liu J, Wang Y, Chen P, Ma Y, Wang S, Tian Y, Wang A, Wang D. AC002454.1 and CDK6 synergistically promote endometrial cell migration and invasion in endometriosis. Reproduction. 2019;157:535\u201343.","journal-title":"Reproduction"},{"key":"1420_CR26","first-page":"3850","volume":"18","author":"J Liu","year":"2018","unstructured":"Liu J, Wang Q, Zhang R, Zhang C, Lin J, Huang X. Identification of LINC01279 as a cell cycle\u2013associated long non\u2013coding RNA in endometriosis with GBA analysis. Mol Med Rep. 2018;18:3850\u20138.","journal-title":"Mol Med Rep"},{"key":"1420_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13578-019-0346-3","volume":"9","author":"Z Liu","year":"2019","unstructured":"Liu Z, Liu L, Zhong Y, Cai M, Gao J, Tan C, Han X, Guo R, Han L. LncRNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through miR-342-3p\/IER3 pathway. Cell Biosci. 2019;9:84.","journal-title":"Cell Biosci"},{"key":"1420_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4103\/jhrs.jhrs_92_24","volume":"17","author":"AH Shayanfard","year":"2024","unstructured":"Shayanfard AH, Salehi Z, Mashayekhi F, Zahiri Z. Modulation of long Non-coding RNA FAS-AS1\/FAS\/Caspase3 Axis in endometriosis: A Cross-sectional study. J Hum Reprod Sci. 2024;17:246\u201354.","journal-title":"J Hum Reprod Sci"},{"key":"1420_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1177\/1933719117734320","volume":"25","author":"M Wang","year":"2018","unstructured":"Wang M, Hao C, Huang X, Bao H, Qu Q, Liu Z, Dai H, He S, Yan W. Aberrant expression of LncRNA (HOXA11-AS1) and homeobox A (HOXA9, HOXA10, HOXA11, and HOXA13) genes in infertile women with endometriosis. Reprod Sci. 2018;25:654\u201361.","journal-title":"Reprod Sci"},{"key":"1420_CR30","doi-asserted-by":"crossref","unstructured":"Revised American Society for Reproductive Medicine classification of endometriosis. 1996. Fertil Steril 1997, 67:817\u2013821.","DOI":"10.1016\/S0015-0282(97)81391-X"},{"key":"1420_CR31","doi-asserted-by":"crossref","unstructured":"Livak KJ. TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2009\u2206\u2206CT method. Methods 25 402\u20138.","DOI":"10.1006\/meth.2001.1262"},{"key":"1420_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ogc.2012.10.002","volume":"39","author":"ML Macer","year":"2012","unstructured":"Macer ML, Taylor HS. Endometriosis and infertility: A review of the pathogenesis and treatment of Endometriosis-associated infertility. Obstet Gynecol Clin N Am. 2012;39:535\u201349.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"1420_CR33","doi-asserted-by":"publisher","first-page":"1020827","DOI":"10.3389\/fendo.2022.1020827","volume":"13","author":"G Bonavina","year":"2022","unstructured":"Bonavina G, Taylor HS. Endometriosis-associated infertility: from pathophysiology to tailored treatment. Front Endocrinol (Lausanne). 2022;13:1020827.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1420_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa1700089","volume":"377","author":"HS Taylor","year":"2017","unstructured":"Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, et al. Treatment of Endometriosis-Associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377:28\u201340.","journal-title":"N Engl J Med"},{"key":"1420_CR35","doi-asserted-by":"crossref","unstructured":"Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, Singh SS, Taylor HS. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 2019, 220:354.e351-354.e312.","DOI":"10.1016\/j.ajog.2018.12.039"},{"key":"1420_CR36","first-page":"65","volume":"6","author":"VA Flores","year":"2025","unstructured":"Flores VA, Sahin C, Taylor HS. Progesterone receptor status predicts aggressiveness of human endometriotic lesions in murine avatars. F S Sci. 2025;6:65\u201372.","journal-title":"F S Sci"},{"key":"1420_CR37","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1210\/jc.2018-01227","volume":"103","author":"VA Flores","year":"2018","unstructured":"Flores VA, Vanhie A, Dang T, Taylor HS. Progesterone receptor status predicts response to progestin therapy in endometriosis. J Clin Endocrinol Metab. 2018;103:4561\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR38","first-page":"1129","volume":"84","author":"HS Taylor","year":"1999","unstructured":"Taylor HS, Igarashi P, Olive DL, Arici A. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab. 1999;84:1129\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR39","doi-asserted-by":"publisher","first-page":"e3000421","DOI":"10.1371\/journal.pbio.3000421","volume":"17","author":"R Tal","year":"2019","unstructured":"Tal R, Shaikh S, Pallavi P, Tal A, L\u00f3pez-Gir\u00e1ldez F, Lyu F, Fang YY, Chinchanikar S, Liu Y, Kliman HJ, et al. Adult bone marrow progenitors become decidual cells and contribute to embryo implantation and pregnancy. PLoS Biol. 2019;17:e3000421.","journal-title":"PLoS Biol"},{"key":"1420_CR40","first-page":"1050","volume":"118","author":"KA Connell","year":"2008","unstructured":"Connell KA, Guess MK, Chen H, Andikyan V, Bercik R, Taylor HS. HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. J Clin Invest. 2008;118:1050\u20135.","journal-title":"J Clin Invest"},{"key":"1420_CR41","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/humrep\/14.5.1328","volume":"14","author":"HS Taylor","year":"1999","unstructured":"Taylor HS, Bagot C, Kardana A, Olive D, Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod. 1999;14:1328\u201331.","journal-title":"Hum Reprod"},{"key":"1420_CR42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/molehr\/gaz040","volume":"25","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhang L, Yu Q, Zhang Y, Yan L, Chen ZJ. The estrogen-regulated LncRNA H19\/miR-216a-5p axis alters stromal cell invasion and migration via ACTA2 in endometriosis. Mol Hum Reprod. 2019;25:550\u201361.","journal-title":"Mol Hum Reprod"},{"key":"1420_CR43","doi-asserted-by":"publisher","first-page":"996","DOI":"10.15252\/emmm.201505245","volume":"7","author":"S Ghazal","year":"2015","unstructured":"Ghazal S, McKinnon B, Zhou J, Mueller M, Men Y, Yang L, Mueller M, Flannery C, Huang Y, Taylor HS. H19 LncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO Mol Med. 2015;7:996\u20131003.","journal-title":"EMBO Mol Med"},{"key":"1420_CR44","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/jcb.29486","volume":"121","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zha J, Zuo M, Yan Q, Song H. Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer. J Cell Biochem. 2020;121:2655\u201363.","journal-title":"J Cell Biochem"},{"key":"1420_CR45","doi-asserted-by":"publisher","first-page":"18845","DOI":"10.1002\/jcb.29200","volume":"120","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang T, Sun X, Wang Y. Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network. J Cell Biochem. 2019;120:18845\u201353.","journal-title":"J Cell Biochem"},{"key":"1420_CR46","doi-asserted-by":"publisher","first-page":"953055","DOI":"10.3389\/fonc.2022.953055","volume":"12","author":"Q Bao","year":"2022","unstructured":"Bao Q, Zheng Q, Wang S, Tang W, Zhang B. LncRNA HOTAIR regulates cell invasion and migration in endometriosis through miR-519b-3p\/PRRG4 pathway. Front Oncol. 2022;12:953055.","journal-title":"Front Oncol"},{"key":"1420_CR47","doi-asserted-by":"publisher","first-page":"112040","DOI":"10.1016\/j.mce.2023.112040","volume":"575","author":"M Yin","year":"2023","unstructured":"Yin M, Wang J, Ying X, Fang Z, Zhang X. Long Non coding RNA, C8orf49, a novel diagnostic and prognostic biomarker, enhances PTEN\/FZD4-mediated cell growth and metastasis by sponging miR-1323 in endometriosis. Mol Cell Endocrinol. 2023;575:112040.","journal-title":"Mol Cell Endocrinol"},{"key":"1420_CR48","first-page":"2218","volume":"22","author":"XY Xu","year":"2018","unstructured":"Xu XY, Zhang J, Qi YH, Kong M, Liu SA, Hu JJ. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway. Eur Rev Med Pharmacol Sci. 2018;22:2218\u201325.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1420_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12905-019-0865-4","volume":"20","author":"AA Delbandi","year":"2020","unstructured":"Delbandi AA, Mahmoudi M, Shervin A, Heidari S, Kolahdouz-Mohammadi R, Zarnani AH. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls. BMC Womens Health. 2020;20:3.","journal-title":"BMC Womens Health"},{"key":"1420_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1039\/C6TX00433D","volume":"6","author":"Q Huang","year":"2017","unstructured":"Huang Q, Lu Q, Chen B, Shen H, Liu Q, Zhou Z, Lei Y. LncRNA-MALAT1 as a novel biomarker of cadmium toxicity regulates cell proliferation and apoptosis. Toxicol Res (Camb). 2017;6:361\u201371.","journal-title":"Toxicol Res (Camb)"},{"key":"1420_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexcr.2019.05.010","volume":"381","author":"S Liu","year":"2019","unstructured":"Liu S, Qiu J, Tang X, Cui H, Zhang Q, Yang Q. LncRNA-H19 regulates cell proliferation and invasion of ectopic endometrium by targeting ITGB3 via modulating miR-124-3p. Exp Cell Res. 2019;381:215\u201322.","journal-title":"Exp Cell Res"},{"key":"1420_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12935-021-02255-6","volume":"21","author":"L You","year":"2021","unstructured":"You L, Wu Q, Xin Z, Zhong H, Zhou J, Jiao L, Song X, Ying B. The long non-coding RNA HOXA11-AS activates ITGB3 expression to promote the migration and invasion of gastric cancer by sponging miR-124-3p. Cancer Cell Int. 2021;21:576.","journal-title":"Cancer Cell Int"},{"key":"1420_CR53","doi-asserted-by":"publisher","first-page":"104312","DOI":"10.1016\/j.jri.2024.104312","volume":"165","author":"X Gao","year":"2024","unstructured":"Gao X, Shao W, Wang J, Gao H, Zhang X, Xia C, Li M, Liu S. Integrin \u03923 enhances Glycolysis and increases lactate production in endometriosis. J Reprod Immunol. 2024;165:104312.","journal-title":"J Reprod Immunol"},{"key":"1420_CR54","doi-asserted-by":"publisher","first-page":"13969","DOI":"10.1038\/s41598-020-70886-2","volume":"10","author":"WT Wei","year":"2020","unstructured":"Wei WT, Wang L, Liang JX, Wang JF, Li Q, Zeng J. LncRNA EIF3J-AS1 enhanced esophageal cancer invasion via regulating AKT1 expression through sponging miR-373-3p. Sci Rep. 2020;10:13969.","journal-title":"Sci Rep"},{"key":"1420_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejogrb.2011.09.040","volume":"160","author":"MT Weigel","year":"2012","unstructured":"Weigel MT, Kr\u00e4mer J, Schem C, Wenners A, Alkatout I, Jonat W, Maass N, Mundhenke C. Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 2012;160:74\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1420_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/gye.16.5.391.402","volume":"16","author":"M Ueda","year":"2002","unstructured":"Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Hung YC, Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Gynecol Endocrinol. 2002;16:391\u2013402.","journal-title":"Gynecol Endocrinol"},{"key":"1420_CR57","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3233\/CH-242163","volume":"88","author":"F Wang","year":"2024","unstructured":"Wang F, Guo Z, Yang G, Yang F, Zhou Q, Lv H. Lnc-216 regulates the miR-143-5p \/MMP2 signaling axis aggravates retinal endothelial cell dysfunction. Clin Hemorheol Microcirc. 2024;88:429\u201342.","journal-title":"Clin Hemorheol Microcirc"},{"key":"1420_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41598-024-83154-4","volume":"15","author":"JF Chen","year":"2025","unstructured":"Chen JF, Ye SZ, Wang KJ, Meng XY, Yang BB, Wu KR, Ma Q. Long non-coding RNA OSTM1-AS1 promotes renal cell carcinoma progression by sponging miR-491-5p and upregulating MMP-9. Sci Rep. 2025;15:359.","journal-title":"Sci Rep"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01420-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T16:03:24Z","timestamp":1748880204000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01420-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01420-0","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Yale University (Approval Protocol No. 2023\u201307113).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}